‘It’s super exciting’ – Breathe Life Sciences secures ARTG listings for Dr Watson range by Adam Sheldon October 9, 2025October 13, 2025 Bioxyne’s subsidiary Breathe Life Sciences has secured a series of Australian Register of Therapeutic Goods (ARTG) […]
Trump CBD video sparks US stock rally – and hope among local firms by Adam Sheldon October 1, 2025October 1, 2025
News in brief: Epsilon receives EU, UK GMP certificates; AGH raises $2.6m via placement; Zelira secures loan notes; Bioxyne’s $5m German order by Steve Jones September 17, 2025February 21, 2026
Bioxyne swings to first significant profit on surging domestic sales by Adam Sheldon August 29, 2025August 29, 2025
News in brief: Wragg joins ANTG; Bioxyne launches legal claim; Epsilon appoints Kaplon by Martin Lane August 28, 2025February 21, 2026
Bioxyne shares spike after upgrade to FY25 revenue forecast by Adam Sheldon June 12, 2025June 12, 2025
Bioxyne stays on course to hit A$25m revenue guidance despite Q3 fall by Steve Jones April 28, 2025April 28, 2025
News in brief: Bioxyne raises A$3m for European expansion; cultivator’s Birchal success; Cann Group receives $750k by Steve Jones March 21, 2025March 27, 2025
Pastilles drive Bioxyne to first-half profit after revenue climbs 171% by Steve Jones March 3, 2025March 3, 2025
